Andrew Tanner, MD
Radiation Oncology · Colorado Springs, CONPI 1679501456
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $455 and has fallen 93.1% since, to $31 in 2025.
Across 71 payments — averaging $24.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$223
- Johnson & Johnson$213
- Daiichi Sankyo Inc.$158
- Visionrt, Inc.$127
- Siemens Medical Solutions USA, Inc.$98
- Novocure Inc.$95
- plus $814 from 20 others
What the payments were for
- Food & beverage$1,729100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $223 |
| Johnson & Johnson(2 entities) | 12 | $213 |
| Daiichi Sankyo Inc. | 3 | $158 |
| Visionrt, Inc. | 3 | $127 |
| Siemens Medical Solutions USA, Inc. | 2 | $98 |
| Novocure Inc. | 4 | $95 |
| Bayer | 4 | $89 |
| EMD Serono, Inc. | 3 | $79 |
| Janssen Scientific Affairs, LLC | 4 | $77 |
| Varian Medical Systems, Inc. | 1 | $72 |
| GSK | 3 | $62 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Myovant Sciences Inc. | 2 | $41 |
| Sanofi | 2 | $35 |
| Monteris Medical Corporation | 1 | $31 |
| Novartis | 1 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Gilead | 1 | $26 |
| Medtronic | 1 | $26 |
| AbbVie | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $14 |
| Eisai Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$125
How this compares
$1,729 in reported general payments places this provider in the 80th percentile of 105 radiation oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Colorado Springs
- Barry GardnerColorado Springs$1K
- Anuj PeddadaColorado Springs$834
- Mihir NaikColorado Springs$516
- Jeffrey OlsenColorado Springs$484
- Alan MonroeColorado Springs$437
- Peter RossiGlenwood Springs$146K
- Suraj SinghGreely$134K
- Meera PatelAurora$112K
- David RabenAurora$61K
- Dustin BootheGreeley$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.